LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM
Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Condense Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Sender:
Lactation Information and Discussion <[log in to unmask]>
Date:
Wed, 26 Mar 2014 18:18:47 -0400
Reply-To:
Lactation Information and Discussion <[log in to unmask]>
Message-ID:
<[log in to unmask]>
Subject:
Medolac
MIME-Version:
1.0
Content-Type:
text/plain; charset="us-ascii"
In-Reply-To:
<[log in to unmask]>
Content-Transfer-Encoding:
quoted-printable
From:
"Nancy E. Wight MD, IBCLC, FABM, FAAP" <[log in to unmask]>
Parts/Attachments:
text/plain (22 lines) 
We have no idea how Medolac is processing the milk.  Ms. Medo has not released any particulars, nor any research regarding her proprietary processing method re how it changes the milk.
As a neonatologist, I need to see the data to prove that her method is safe and preserves more of the milk's immunologic properties than other methods.
It is still a commercial company - no guarantee that all the infants who need donor milk will get it.

Nancy
Nancy E. Wight MD, IBCLC, FABM, FAAP 
Attending Neonatologist, Sharp Mary Birch Hospital for Women 
Medical Director, Sharp HealthCare Lactation Service 
San Diego, CA, USA 
[log in to unmask]

             ***********************************************

Archives: http://community.lsoft.com/archives/LACTNET.html
To reach list owners: [log in to unmask]
Mail all list management commands to: [log in to unmask]
COMMANDS:
1. To temporarily stop your subscription write in the body of an email: set lactnet nomail
2. To start it again: set lactnet mail
3. To unsubscribe: unsubscribe lactnet
4. To get a comprehensive list of rules and directions: get lactnet welcome

ATOM RSS1 RSS2